- 专利标题: DNA-PEPTIDE COMBINATION VACCINE
-
申请号: US15528502申请日: 2015-11-20
-
公开(公告)号: US20170258895A1公开(公告)日: 2017-09-14
- 发明人: Hironori NAKAGAMI , Ryuichi MORISHITA , Hiroshi KORIYAMA , Hideki TOMIOKA , Kenji NAOHARA
- 申请人: ANGES MG, INC. , OSAKA UNIVERSITY , DS PHARMA ANIMAL HEALTH CO., LTD.
- 申请人地址: JP Ibaraki-shi, Osaka JP Suita-shi, Osaka JP Osaka-shi, Osaka
- 专利权人: ANGES MG, INC.,OSAKA UNIVERSITY,DS PHARMA ANIMAL HEALTH CO., LTD.
- 当前专利权人: ANGES MG, INC.,OSAKA UNIVERSITY,DS PHARMA ANIMAL HEALTH CO., LTD.
- 当前专利权人地址: JP Ibaraki-shi, Osaka JP Suita-shi, Osaka JP Osaka-shi, Osaka
- 优先权: JP2014-235736 20141120
- 国际申请: PCT/JP2015/082778 WO 20151120
- 主分类号: A61K39/29
- IPC分类号: A61K39/29 ; A61K39/00 ; C12N7/00
摘要:
The present invention provides a combination preparation for inducing a specific immune response to an antigenic peptide, which contains (I) the antigenic peptide, and (II) an expression vector encoding a chimeric hepatitis B virus core antigen polypeptide, into which the antigenic peptide has been inserted or added, wherein said antigenic peptide is inserted in a region of amino acid residues 74-87 or 130-138 of the hepatitis B virus core antigen polypeptide, or added to the N-terminal or C-terminal of the hepatitis B virus core antigen polypeptide, wherein the antigenic peptide of (I) and the expression vector of (II) are substantially simultaneously administered to a subject.
公开/授权文献
- US10695420B2 DNA-peptide combination vaccine 公开/授权日:2020-06-30
信息查询